<DOC>
	<DOCNO>NCT00594620</DOCNO>
	<brief_summary>To determine efficacy soy/isoflavone supplementation hot flash men treat luteinizing hormone-releasing hormone ( LHRH ) agonist therapy control advanced prostate cancer</brief_summary>
	<brief_title>Soy Derivatives Control Hot Flashes Men Androgen Deprivation Therapy</brief_title>
	<detailed_description>Literature show low dose estrogen control hot flash men androgen deprivation high risk thromboembolic event . Soy derivatives contain isoflavones , type phytoestrogen , evaluate peri-menopausal woman possible safer alternative synthetic estrogen similar study perform effect men androgen deprivation therapy prostate cancer .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Histologically proven adenocarcinoma prostate treatment prostate cancer ( radical prostatectomy , radiation therapy , etc . ) biochemical/clinical relapse start antiandrogens documented history hot flash History MI , DVT , CVA peanut allergy untreated hypothyroidism must medical treatment hot flash 2 week enrollment study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>